|
US3758475A
(en)
|
1971-07-20 |
1973-09-11 |
Sandoz Ag |
Pyrido(2,3-d)pyrimidin 2 ones
|
|
EP0081756B1
(en)
|
1981-12-14 |
1985-05-15 |
MEDEA RESEARCH S.r.l. |
New compounds with antiinflammatory and antitussive activity, process for their preparation and relative pharmaceutical compositions
|
|
IT1226048B
(it)
|
1981-12-14 |
1990-12-10 |
Medea Res Srl |
Composti ad attivita'antiinfiammatoria, processo per la loro preparazione e composizioni farmaceutiche relative
|
|
US4501729A
(en)
|
1982-12-13 |
1985-02-26 |
Research Corporation |
Aerosolized amiloride treatment of retained pulmonary secretions
|
|
EP0278374A3
(de)
*
|
1987-02-06 |
1989-03-01 |
Pharmatest Apparatebau Gmbh |
Vorrichtung zur Bestimmung der Wirkstoff-Freigabe von pharmazeutischen Produkten
|
|
US5981714A
(en)
|
1990-03-05 |
1999-11-09 |
Genzyme Corporation |
Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor
|
|
JP3167762B2
(ja)
|
1990-11-27 |
2001-05-21 |
武田薬品工業株式会社 |
ピリドピリダジン誘導体およびその用途
|
|
US5612360A
(en)
|
1992-06-03 |
1997-03-18 |
Eli Lilly And Company |
Angiotensin II antagonists
|
|
CA2107196A1
(en)
|
1992-09-29 |
1994-03-30 |
Mitsubishi Chemical Corporation |
Carboxamide derivatives
|
|
US6060024A
(en)
*
|
1993-07-14 |
2000-05-09 |
Zymark Corporation |
Automatic dissolution testing system
|
|
GB9317764D0
(en)
|
1993-08-26 |
1993-10-13 |
Pfizer Ltd |
Therapeutic compound
|
|
KR100342275B1
(ko)
|
1993-10-21 |
2002-12-05 |
지.디. 썰 엘엘씨 |
산화질소신타제저해제로서유용한아미디노유도체
|
|
DE4405712A1
(de)
|
1994-02-23 |
1995-08-24 |
Basf Ag |
Substituierte Naphthyridine und deren Verwendung
|
|
CZ289317B6
(cs)
|
1994-04-11 |
2002-01-16 |
Sankyo Company Limited |
Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití
|
|
RU2154064C2
(ru)
|
1994-09-27 |
2000-08-10 |
Жансен Фармасетика Н.В. |
N-замещенные пиперидинилбензоаты, их n-оксидные формы, фармацевтически приемлемые соли присоединения кислот и стереохимически изомерные формы, способы их получения, фармацевтическая композиция на их основе и промежуточный продукт
|
|
DK0788600T3
(da)
*
|
1994-10-28 |
2002-08-05 |
Sophion Bioscience As |
Patch-clamp-apparat og -teknik med høj gennemgang og lave fluidvolumenkrav
|
|
US5656256A
(en)
|
1994-12-14 |
1997-08-12 |
The University Of North Carolina At Chapel Hill |
Methods of treating lung disease by an aerosol containing benzamil or phenamil
|
|
US5510379A
(en)
|
1994-12-19 |
1996-04-23 |
Warner-Lambert Company |
Sulfonate ACAT inhibitors
|
|
WO1997036876A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AU4159297A
(en)
|
1996-08-23 |
1998-03-06 |
Agouron Acquisition Corp. |
Neuropeptide-y ligands
|
|
CA2276081A1
(en)
|
1996-12-30 |
1998-07-09 |
Lekhanh O. Tran |
Inhibitors of farnesyl-protein transferase
|
|
US5948814A
(en)
|
1997-02-20 |
1999-09-07 |
The Curators Of The University Of Missouri |
Genistein for the treatment of cystic fibrosis
|
|
WO1998047868A1
(en)
|
1997-04-18 |
1998-10-29 |
Smithkline Beecham Plc |
Heterocycle-containing urea derivatives as 5ht1a, 5ht1b and 5ht1d receptor antagonists
|
|
WO1999018066A1
(en)
|
1997-10-02 |
1999-04-15 |
Sankyo Company, Limited |
Amidocarboxylic acid derivatives
|
|
ES2216495T3
(es)
|
1998-02-17 |
2004-10-16 |
G.D. SEARLE & CO. |
Procedimiento para la resolucion enzimatica de lactamas.
|
|
EP1086078B1
(en)
|
1998-06-08 |
2003-02-05 |
Schering Corporation |
Neuropeptide y5 receptor antagonists
|
|
US6426331B1
(en)
|
1998-07-08 |
2002-07-30 |
Tularik Inc. |
Inhibitors of STAT function
|
|
AUPP609198A0
(en)
|
1998-09-22 |
1998-10-15 |
Curtin University Of Technology |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
|
DE69926806D1
(de)
|
1998-12-18 |
2005-09-22 |
Bristol Myers Squibb Pharma Co |
N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
|
|
KR100437587B1
(ko)
|
1999-02-24 |
2004-06-30 |
에프. 호프만-라 로슈 아게 |
3-페닐피리딘 유도체 및 그의 뉴로키닌-1 수용체길항제로서의 용도
|
|
TR200102490T2
(tr)
|
1999-02-24 |
2001-12-21 |
F.Hoffmann-La Roche Ag |
Fenil ve piridinil türevleri
|
|
PT1035115E
(pt)
|
1999-02-24 |
2005-01-31 |
Hoffmann La Roche |
Derivados de 4-fenilpiridina e a sua utilizacao como antagonistas do receptor nk-1
|
|
UA71971C2
(en)
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
|
BR0012291A
(pt)
|
1999-06-18 |
2002-03-26 |
Bayer Ag |
Fenoxifluorpirimidinas
|
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
|
WO2001046165A2
(en)
|
1999-12-16 |
2001-06-28 |
Novartis Ag |
N-heteroaryl-amides and their use as parasiticides
|
|
EP1248869A2
(en)
|
2000-01-07 |
2002-10-16 |
Transform Pharmaceuticals, Inc. |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
US7122309B2
(en)
*
|
2000-01-15 |
2006-10-17 |
Avigenics, Inc. |
High throughput screening assay for detecting a DNA sequence
|
|
WO2001054690A1
(en)
|
2000-01-28 |
2001-08-02 |
Biogen, Inc. |
Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
|
|
WO2001056989A2
(en)
|
2000-02-01 |
2001-08-09 |
Cor Therapeutics, Inc. |
Inhibitors of factor xa
|
|
US20010047100A1
(en)
|
2000-04-26 |
2001-11-29 |
Kjaersgaard Hans Joergen |
Chiral imidazoyl intermediates for the synthesis of 2-(4-imidazoyl)-cyclopropyl derivatives
|
|
WO2001083517A1
(en)
|
2000-05-03 |
2001-11-08 |
Tularik Inc. |
Stat4 and stat6 binding dipeptide derivatives
|
|
US6499984B1
(en)
|
2000-05-22 |
2002-12-31 |
Warner-Lambert Company |
Continuous production of pharmaceutical granulation
|
|
CN1386118A
(zh)
|
2000-06-01 |
2002-12-18 |
布里斯托尔-迈尔斯斯奎布药品公司 |
作为Aβ蛋白产生抑制剂的被环状琥珀酸酯取代的内酰胺类化合物
|
|
TWI259180B
(en)
|
2000-08-08 |
2006-08-01 |
Hoffmann La Roche |
4-Phenyl-pyridine derivatives
|
|
WO2002022605A1
(en)
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
|
WO2002028348A2
(en)
|
2000-10-04 |
2002-04-11 |
The Children's Hospital Of Philadelphia |
Compositions and methods for treatment of cystic fibrosis
|
|
GB2367816A
(en)
|
2000-10-09 |
2002-04-17 |
Bayer Ag |
Urea- and thiourea-containing derivatives of beta-amino acids
|
|
ATE269856T1
(de)
|
2000-10-20 |
2004-07-15 |
Merck Patent Gmbh |
Chirale binaphtol-verbindungen
|
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
|
JP4323802B2
(ja)
|
2000-12-01 |
2009-09-02 |
エムジーアイ・ジーピー・インコーポレーテッド |
化合物およびその使用
|
|
GB0102687D0
(en)
|
2001-02-02 |
2001-03-21 |
Pharmacia & Upjohn Spa |
Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
|
|
US6531597B2
(en)
|
2001-02-13 |
2003-03-11 |
Hoffmann-La Roche Inc. |
Process for preparation of 2-phenyl acetic acid derivatives
|
|
US6962674B2
(en)
*
|
2001-02-28 |
2005-11-08 |
Varian, Inc. |
Dissolution test apparatus
|
|
WO2003084997A1
(en)
|
2001-04-10 |
2003-10-16 |
Transtech Pharma, Inc. |
Probes, systems and methods for drug discovery
|
|
CA2444395C
(en)
|
2001-04-23 |
2010-12-21 |
F. Hoffmann-La Roche Ag |
Use of nk-1 receptor antagonists against benign prostatic hyperplasia
|
|
HUP0400316A2
(hu)
|
2001-05-22 |
2005-02-28 |
Neurogen Corporation |
CRF1 modulátor hatású 5-szubsztituált-2-arilpiridin származékok és ezeket tartalmazó gyógyszerkészítmények
|
|
US20030083345A1
(en)
|
2001-07-10 |
2003-05-01 |
Torsten Hoffmann |
Method of treatment and/or prevention of brain, spinal or nerve injury
|
|
US6627646B2
(en)
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
|
WO2003007888A2
(en)
|
2001-07-20 |
2003-01-30 |
Adipogenix, Inc. |
Fat accumulation-modulating compounds
|
|
CA2448737C
(en)
|
2001-07-20 |
2010-06-01 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
AU2002333524A1
(en)
|
2001-09-11 |
2003-03-24 |
Glaxosmithkline K.K. |
Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
|
|
PA8557501A1
(es)
|
2001-11-12 |
2003-06-30 |
Pfizer Prod Inc |
Benzamida, heteroarilamida y amidas inversas
|
|
JP2003155285A
(ja)
|
2001-11-19 |
2003-05-27 |
Toray Ind Inc |
環状含窒素誘導体
|
|
JP2003221386A
(ja)
|
2001-11-26 |
2003-08-05 |
Takeda Chem Ind Ltd |
二環性誘導体、その製造法およびその用途
|
|
PL370989A1
(en)
|
2001-12-21 |
2005-06-13 |
Novo Nordisk A/S |
Amide derivatives as gk activators
|
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
|
TW200304820A
(en)
|
2002-03-25 |
2003-10-16 |
Avanir Pharmaceuticals |
Use of benzimidazole analogs in the treatment of cell proliferation
|
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
|
FR2840807B1
(fr)
|
2002-06-12 |
2005-03-11 |
|
Composition cosmetique de soin et/ou de maquillage, structuree par des polymeres silicones et des organogelateurs, sous forme rigide
|
|
GB0221443D0
(en)
|
2002-09-16 |
2002-10-23 |
Glaxo Group Ltd |
Pyridine derivates
|
|
WO2004035571A1
(en)
|
2002-10-15 |
2004-04-29 |
Rigel Pharmaceuticals, Inc. |
Substituted indoles and their use as hcv inhibitors
|
|
EP1558576A4
(en)
|
2002-10-30 |
2008-04-16 |
Merck & Co Inc |
PIPERIDINYLCYCLOPENTYLARYLBENZYLAMIDE MODULATORS OF CHEMOKIN RECEPTORACTIVITY
|
|
WO2004040295A1
(en)
*
|
2002-10-31 |
2004-05-13 |
Nanostream, Inc. |
Parallel detection chromatography systems
|
|
MXPA05006367A
(es)
|
2002-12-12 |
2005-08-29 |
Pharmacia Corp |
Metodo de uso de compuestos de aminocianopiridina como inhibidores de cinasa-2 de proteina activada de cinasa de proteina activada por mitogeno.
|
|
DE60336850D1
(en)
|
2003-01-06 |
2011-06-01 |
Lilly Co Eli |
Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
|
|
RU2351590C2
(ru)
|
2003-02-10 |
2009-04-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения диариламина
|
|
WO2004080972A1
(en)
|
2003-03-12 |
2004-09-23 |
Vertex Pharmaceuticals Incorporated |
Pirazole modulators of atp-binding cassette transporters
|
|
BRPI0409914A
(pt)
|
2003-04-30 |
2006-04-25 |
Inst For Pharm Discovery Inc |
ácidos carboxìlicos substituìdos
|
|
EP1646615B1
(en)
|
2003-06-06 |
2009-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
|
CA2530075C
(en)
|
2003-06-27 |
2012-08-21 |
Harvey Pollard |
Amphiphilic pyridinium compounds, method of making and use thereof
|
|
JP2005053902A
(ja)
|
2003-07-18 |
2005-03-03 |
Nippon Nohyaku Co Ltd |
フェニルピリジン類、その中間体及びこれを有効成分とする除草剤
|
|
AR045582A1
(es)
|
2003-09-05 |
2005-11-02 |
Neurogen Corp |
Piridinas pirazinas y pirimidinas heteroarilo fusionadas como ligandos receptores de crf1
|
|
ZA200602755B
(en)
|
2003-09-06 |
2007-06-27 |
Vertex Pharma |
Modulators of ATP-binding cassette transporters
|
|
US7534894B2
(en)
|
2003-09-25 |
2009-05-19 |
Wyeth |
Biphenyloxy-acids
|
|
US20050070718A1
(en)
|
2003-09-30 |
2005-03-31 |
Abbott Gmbh & Co. Kg |
Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
|
|
MXPA06004005A
(es)
|
2003-10-08 |
2006-06-28 |
Vertex Pharma |
Moduladores de transportadores con casete de union con atp.
|
|
FR2861304B1
(fr)
|
2003-10-23 |
2008-07-18 |
Univ Grenoble 1 |
Modulateurs des canaux cftr
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
JP4869072B2
(ja)
|
2003-11-14 |
2012-02-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｐ結合カセットトランスポーターのモジュレーターとして有用なチアゾールおよびオキサゾール
|
|
EP1687001A2
(en)
|
2003-11-19 |
2006-08-09 |
Glaxo Group Limited |
Use of cyclooxygenase-2 selective inhibitors for the treatment of schizophrenic disorders
|
|
MXPA06008606A
(es)
|
2004-01-30 |
2007-04-13 |
Vertex Pharma |
Moduladores de transportadores con casete de union a atp.
|
|
US7977322B2
(en)
|
2004-08-20 |
2011-07-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
|
CN100567270C
(zh)
|
2004-02-19 |
2009-12-09 |
万有制药株式会社 |
磺酰胺衍生物
|
|
ES2241496B1
(es)
|
2004-04-15 |
2006-12-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridina.
|
|
EP1734820A4
(en)
|
2004-04-16 |
2008-01-23 |
Neurogen Corp |
Imidazopyrrazine, imidazopyridine, and imidazo-pyrimidine as CRF1 receptor ligands
|
|
US7585885B2
(en)
|
2004-04-22 |
2009-09-08 |
Eli Lilly And Company |
Pyrrolidine derivatives useful as BACE inhibitors
|
|
US7618978B2
(en)
|
2004-04-22 |
2009-11-17 |
Eli Lilly And Company |
Amides as BACE inhibitors
|
|
CA2568499A1
(en)
|
2004-06-01 |
2005-12-15 |
Tm Bioscience Corporation |
Method of detecting cystic fibrosis associated mutations
|
|
TWI428271B
(zh)
*
|
2004-06-09 |
2014-03-01 |
Smithkline Beecham Corp |
生產藥物之裝置及方法
|
|
US8354427B2
(en)
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
|
LT2502911T
(lt)
|
2004-06-24 |
2017-09-11 |
Vertex Pharmaceuticals Incorporated |
Atp surišančios kasetės transporterių moduliatoriai
|
|
US20140343098A1
(en)
|
2004-06-24 |
2014-11-20 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
BRPI0512829A
(pt)
|
2004-07-01 |
2008-04-08 |
Warner Lambert Co |
preparação de composições farmacêuticas contendo nanopartìculas
|
|
CA2572292A1
(en)
|
2004-07-02 |
2006-02-09 |
Advancis Pharmaceutical Corporation |
Tablet for pulsed delivery
|
|
ZA200700811B
(en)
|
2004-08-06 |
2008-10-29 |
Otsuka Pharma Co Ltd |
Aromatic compound
|
|
EP1794135A1
(en)
|
2004-09-27 |
2007-06-13 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
BRPI0516093A
(pt)
|
2004-10-12 |
2008-08-19 |
Astrazeneca Ab |
derivado de quinazolina, processo para a preparação do mesmo, composição farmacêutica, uso de um derivado de quinazolina, e, método para tratamento de distúrbios proliferativos celulares em um animal de sanque quente
|
|
WO2006051394A1
(en)
|
2004-11-15 |
2006-05-18 |
Pfizer Products Inc. |
Azabenzoxazoles for the treatment of cns disorders
|
|
CA2589495C
(en)
|
2004-12-15 |
2013-10-01 |
Dompe Pha.R.Ma. S.P.A. |
2-arylpropionic acid derivatives and pharmaceutical compositions containing them
|
|
JP4790260B2
(ja)
|
2004-12-22 |
2011-10-12 |
出光興産株式会社 |
アントラセン誘導体を用いた有機エレクトロルミネッセンス素子
|
|
KR101276987B1
(ko)
*
|
2005-01-25 |
2013-06-25 |
바이엘 크롭사이언스 아게 |
아인산, 포세틸-ａｌ 또는 두 가지 모두의 동시적 분석방법
|
|
WO2006080884A1
(en)
|
2005-01-27 |
2006-08-03 |
Astrazeneca Ab |
Novel biaromatic compounds, inhibitors of the p2x7-receptor
|
|
US7888374B2
(en)
|
2005-01-28 |
2011-02-15 |
Abbott Laboratories |
Inhibitors of c-jun N-terminal kinases
|
|
WO2006082952A1
(ja)
|
2005-02-01 |
2006-08-10 |
Takeda Pharmaceutical Company Limited |
アミド化合物
|
|
EP2363128B1
(en)
|
2005-03-11 |
2016-02-17 |
Vertex Pharmaceuticals Incorporated |
Indole modulators of ATP-binding cassette transporters
|
|
US7402596B2
(en)
|
2005-03-24 |
2008-07-22 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
|
EP1710246A1
(en)
|
2005-04-08 |
2006-10-11 |
Schering Aktiengesellschaft |
Sulfoximine-pyrimidine Macrocycles and the salts thereof, a process for making them, and their pharmaceutical use against cancer
|
|
TW200716594A
(en)
|
2005-04-18 |
2007-05-01 |
Neurogen Corp |
Substituted heteroaryl CB1 antagonists
|
|
WO2006113919A2
(en)
|
2005-04-19 |
2006-10-26 |
Bayer Pharmaceuticals Corporation |
Aryl alkyl acid derivatives for and use thereof
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
EP1891018B1
(en)
|
2005-05-24 |
2011-11-16 |
Vertex Pharmaceuticals, Inc. |
Modulators of atp-binding cassette transporters
|
|
JP2008545744A
(ja)
|
2005-06-02 |
2008-12-18 |
バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト |
フェニルアルキル置換ヘテロアリール誘導体
|
|
JP2008543919A
(ja)
|
2005-06-21 |
2008-12-04 |
アステックス・セラピューティクス・リミテッド |
医薬化合物
|
|
CN2856973Y
(zh)
*
|
2005-07-25 |
2007-01-10 |
中国环境科学研究院 |
旋转振荡装置
|
|
TW200738331A
(en)
*
|
2005-07-26 |
2007-10-16 |
Showa Denko Kk |
Method for analyzing low-molecular-weight compound in sample containing water-soluble polymer and low-molecular-weight compound
|
|
ES2367844T3
(es)
|
2005-08-11 |
2011-11-10 |
Vertex Pharmaceuticals, Inc. |
Moduladores del regulador de la conductancia transmembrana de la fibrosis quística.
|
|
ATE512145T1
(de)
|
2005-08-11 |
2011-06-15 |
Vertex Pharma |
Modulatoren des cystic fibrosis transmembrane conductance regulators
|
|
EA013909B1
(ru)
|
2005-09-09 |
2010-08-30 |
Смитклайн Бичам Корпорейшн |
Пиридиновые производные и их применение для лечения психотических расстройств
|
|
CN103893145A
(zh)
|
2005-09-23 |
2014-07-02 |
弗·哈夫曼-拉罗切有限公司 |
新型制剂
|
|
AU2006302371A1
(en)
|
2005-10-06 |
2007-04-19 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding cassette transporters
|
|
DK1940821T3
(da)
|
2005-10-19 |
2013-06-10 |
Gruenenthal Gmbh |
Nye vanilloid-receptorligander og deres anvendelse til fremstilling af lægemidler.
|
|
WO2007054480A1
(en)
|
2005-11-08 |
2007-05-18 |
N.V. Organon |
2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
|
|
US20120232059A1
(en)
|
2005-11-08 |
2012-09-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette Transporters
|
|
EP1945632B1
(en)
|
2005-11-08 |
2013-09-18 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic modulators of atp-binding cassette transporters
|
|
JP5103403B2
(ja)
|
2005-12-05 |
2012-12-19 |
スミスクライン ビーチャム コーポレーション |
２−ピリミジニルピラゾロピリジンＥｒｂＢキナーゼ阻害剤
|
|
CA2634113A1
(en)
|
2005-12-24 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Quinolin- 4 - one derivatives as modulators of abc transporters
|
|
AU2006331565A1
(en)
|
2005-12-27 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Compounds useful in CFTR assays and methods therewith
|
|
WO2007079139A2
(en)
|
2005-12-28 |
2007-07-12 |
Vertex Pharmaceuticals, Inc. |
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
AU2006336504C9
(en)
|
2005-12-28 |
2015-05-14 |
Vertex Pharmaceuticals Incorporated |
1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
|
|
US7671221B2
(en)
|
2005-12-28 |
2010-03-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
EP1966585A2
(en)
*
|
2005-12-30 |
2008-09-10 |
Caliper Life Sciences, Inc. |
Integrated dissolution processing and sample transfer system
|
|
US7645789B2
(en)
|
2006-04-07 |
2010-01-12 |
Vertex Pharmaceuticals Incorporated |
Indole derivatives as CFTR modulators
|
|
US10022352B2
(en)
|
2006-04-07 |
2018-07-17 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
|
NZ571803A
(en)
|
2006-04-07 |
2011-12-22 |
Vertex Pharma |
Amide indole derivatives as modulators of ATP-binding cassette transporters
|
|
EP2021797B1
(en)
|
2006-05-12 |
2011-11-23 |
Vertex Pharmaceuticals, Inc. |
Compositions of n-ý2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl¨-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
EP1882948A2
(de)
*
|
2006-07-28 |
2008-01-30 |
Qiagen GmbH |
Vorrichtung zur Probenverarbeitung
|
|
CA2668305C
(en)
|
2006-11-03 |
2017-01-03 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as cftr modulators
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
US7754739B2
(en)
|
2007-05-09 |
2010-07-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
|
JP2010510974A
(ja)
|
2006-11-27 |
2010-04-08 |
ノバルティス アーゲー |
置換ジヒドロイミダゾールおよび腫瘍の処置におけるその使用
|
|
CN101206205B
(zh)
*
|
2006-12-22 |
2011-08-10 |
中国科学院大连化学物理研究所 |
微流量液相色谱在线大体积进样的方法和专用装置
|
|
CN101209399B
(zh)
*
|
2006-12-27 |
2010-07-28 |
中国科学院沈阳应用生态研究所 |
一种往复式振荡机样品安放与固定装置
|
|
CN101210906A
(zh)
*
|
2006-12-29 |
2008-07-02 |
电子科技大学 |
高通量自动化药物筛选实验检测系统
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
US8969386B2
(en)
|
2007-05-09 |
2015-03-03 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
|
WO2008147952A1
(en)
|
2007-05-25 |
2008-12-04 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
US20110177999A1
(en)
|
2007-08-09 |
2011-07-21 |
Vertex Pharmaceuticals Incorporated |
Therapeutic Combinations Useful in Treating CFTR Related Diseases
|
|
HUE028426T2
(en)
|
2007-08-24 |
2016-12-28 |
Vertex Pharma |
Isothiazolopyridinones for (inter alia) treating cystic fibrosis
|
|
DE102007042754A1
(de)
|
2007-09-07 |
2009-03-12 |
Bayer Healthcare Ag |
Substituierte 6-Phenylnikotinsäuren und ihre Verwendung
|
|
AU2008298545B2
(en)
|
2007-09-14 |
2013-12-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
WO2009038683A2
(en)
|
2007-09-14 |
2009-03-26 |
Vertex Pharmaceuticals Incorporated |
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
FR2921657A1
(fr)
|
2007-09-28 |
2009-04-03 |
Sanofi Aventis Sa |
Derives de nicotinamide, leur preparation et leur application en therapeutique
|
|
SI2217572T1
(sl)
|
2007-11-16 |
2014-05-30 |
Vertex Pharmaceuticals Incorporated |
Izokinolinski modulatorji prenaĺ alcev z atp-vezavno kaseto
|
|
DE102007058718A1
(de)
*
|
2007-12-06 |
2009-06-10 |
Erweka Gmbh |
Vorrichtung und Verfahren zur automatischen Freisetzung und Messung von Wirkstoffen aus einer Arzneizubereitung
|
|
US20100036130A1
(en)
|
2007-12-07 |
2010-02-11 |
Vertex Pharmaceuticals Incorporated |
Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
|
|
WO2009076141A2
(en)
|
2007-12-07 |
2009-06-18 |
Vertex Pharmaceuticals Incorporated |
Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
|
SI2225230T1
(sl)
|
2007-12-07 |
2017-03-31 |
Vertex Pharmaceuticals Incorporated |
Trdne oblike 3-(6-(1-2,2-difluorobenzo(d)(1,3)dioxol-5-il)ciklopropan- karboksamido)-3-metilpiridin-2-il) benzojske kisline
|
|
EP2639224B1
(en)
|
2007-12-07 |
2016-08-24 |
Vertex Pharmaceuticals Incorporated |
Process for producing cycloalkylcarboxiamido-pyridine benzoic acids
|
|
JP5637859B2
(ja)
|
2007-12-13 |
2014-12-10 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
嚢胞性線維症膜コンダクタンスレギュレーターのモジュレーター
|
|
US20090173146A1
(en)
*
|
2008-01-07 |
2009-07-09 |
Matthias Pursch |
Temperature programmed low thermal mass fast liquid chromatography analysis system
|
|
NZ720282A
(en)
|
2008-02-28 |
2017-12-22 |
Vertex Pharma |
Heteroaryl derivatives as cftr modulators
|
|
WO2009111228A2
(en)
*
|
2008-02-29 |
2009-09-11 |
Waters Technologies Corporation |
Chromatography-based monitoring and control of multiple process streams
|
|
EP2271621B1
(en)
|
2008-03-31 |
2013-11-20 |
Vertex Pharmaceuticals Incorporated |
Pyridyl derivatives as cftr modulators
|
|
GB0813709D0
(en)
|
2008-07-26 |
2008-09-03 |
Univ Dundee |
Method and product
|
|
HRP20180328T1
(hr)
|
2008-08-13 |
2018-04-20 |
Vertex Pharmaceuticals Inc. |
FARMACEUTSKI PRIPRAVAK N-[2,4-bis(1,1-DIMETILETIL)-5-HIDROKSIFENIL]-1,4-DIHIDRO-4-OKSOKINOLIN-3-KARBOKSAMIDA I NJEGOVO DAVANJE
|
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
|
US20100256184A1
(en)
|
2008-08-13 |
2010-10-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
|
JP2012504143A
(ja)
|
2008-09-29 |
2012-02-16 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
３−（６−（１−（２，２−ジフルオロベンゾ［ｄ］［１，３］ジオキソール−５−イル）シクロプロパンカルボキサミド）−３−メチルピリジン−２−イル）安息香酸の用量単位
|
|
US20110257223A1
(en)
|
2008-10-23 |
2011-10-20 |
Vertex Pharmaceuticals Incorporated |
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
|
|
US8314239B2
(en)
|
2008-10-23 |
2012-11-20 |
Vertex Pharmaceutical Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
NZ592685A
(en)
|
2008-10-23 |
2013-04-26 |
Vertex Pharma |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
PT2358680E
(pt)
|
2008-10-23 |
2013-05-14 |
Vertex Pharma |
Formas sólidas de n-(4-(7-azabiciclo[2.2.1]heptan-7-il)-2- (trifluorometil)fenil)-4-oxo- 5-(trifluorometil)-1,4- dihidroquinolina-3-carboxamida
|
|
BRPI0919895B1
(pt)
*
|
2008-10-31 |
2019-08-13 |
Bio Merieux Inc |
método para identificação de um microorganismo desconhecido a partir de uma amostra de teste
|
|
EP2365972B1
(en)
|
2008-11-06 |
2014-12-17 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
UA104876C2
(uk)
|
2008-11-06 |
2014-03-25 |
Вертекс Фармасьютікалз Інкорпорейтед |
Модулятори atф-зв'язувальних касетних транспортерів
|
|
EP2382197B1
(en)
|
2008-12-30 |
2016-10-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
HRP20181261T1
(hr)
|
2009-03-20 |
2018-12-14 |
Vertex Pharmaceuticals Incorporated |
Modulatori regulatora transmembranske provodljivosti cistične fibroze
|
|
SI2408750T1
(sl)
|
2009-03-20 |
2015-11-30 |
Vertex Pharmaceuticals Incorporated |
Postopek za izdelavo modulatorjev cistično-fibroznega transmembranskega regulatorja prevodnosti
|
|
EP2427166B1
(en)
|
2009-05-07 |
2013-10-16 |
Gea Pharma Systems Limited |
Tablet production module and method for continuous production of tablets
|
|
US8053866B2
(en)
|
2009-08-06 |
2011-11-08 |
Freescale Semiconductor, Inc. |
Varactor structures
|
|
BR112012006031A2
(pt)
|
2009-09-17 |
2019-09-24 |
Vertex Pharma |
processo para preparação de compostos azabicíclicos.
|
|
EP2486399A2
(en)
*
|
2009-10-08 |
2012-08-15 |
GE Healthcare UK Limited |
Multi-stream high-pressure liquid chromatography module
|
|
US20110098311A1
(en)
|
2009-10-22 |
2011-04-28 |
Vertex Pharmaceuticals Incorported |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
|
WO2011050220A1
(en)
|
2009-10-23 |
2011-04-28 |
Vertex Pharmaceuticals Incorporated |
Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
|
|
CN102648182A
(zh)
|
2009-10-23 |
2012-08-22 |
沃泰克斯药物股份有限公司 |
用于制备囊性纤维化跨膜传导调节因子的调节剂的方法
|
|
CN201586570U
(zh)
*
|
2010-02-03 |
2010-09-22 |
兰州大学 |
塑料离心过滤管
|
|
US8471029B2
(en)
|
2010-03-19 |
2013-06-25 |
Vertex Pharmaceutical Incorporated |
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
US20110251253A1
(en)
|
2010-03-25 |
2011-10-13 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
HRP20160682T1
(hr)
|
2010-04-07 |
2016-07-29 |
Vertex Pharmaceuticals Incorporated |
Čvrsti oblici 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksiamido)-3-metilpiridin-2-il)benzojeve kiseline
|
|
HRP20211752T1
(hr)
|
2010-04-07 |
2022-02-18 |
Vertex Pharmaceuticals Incorporated |
Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena
|
|
NZ603044A
(en)
|
2010-04-22 |
2015-08-28 |
Vertex Pharma |
Pharmaceutical compositions comprising cftr modulators and administrations thereof
|
|
ES2608474T3
(es)
|
2010-04-22 |
2017-04-11 |
Vertex Pharmaceuticals Incorporated |
Proceso de producción de compuestos indol cycloalkylcarboxamido
|
|
AU2011242454A1
(en)
|
2010-04-22 |
2012-11-08 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions and administrations thereof
|
|
CA2796642A1
(en)
|
2010-04-22 |
2011-10-27 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions and administrations thereof
|
|
CA2798412A1
(en)
|
2010-05-20 |
2011-11-24 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions and administrations thereof
|
|
TW201202250A
(en)
|
2010-05-20 |
2012-01-16 |
Vertex Pharma |
Processes for producing modulators of cystic fibrosis transmembrane conductance regulator
|
|
US8563593B2
(en)
|
2010-06-08 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
|
|
CA2808501A1
(en)
|
2010-08-23 |
2012-03-01 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration therof
|
|
RU2013113627A
(ru)
|
2010-08-27 |
2014-10-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Фармацевтическая композиция и ее введения
|
|
CN102058889A
(zh)
|
2010-11-05 |
2011-05-18 |
王定豪 |
包含抗凝血类药物的分散片及其应用
|
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
KR101387872B1
(ko)
*
|
2011-05-11 |
2014-04-22 |
경상대학교산학협력단 |
생물 검체 내 카페인 및 카테킨을 동시분석하는 방법
|
|
CN102507770A
(zh)
*
|
2011-10-25 |
2012-06-20 |
中国检验检疫科学研究院 |
检测化妆品中六氯酚的高效液相色谱法
|
|
EP2773349A1
(en)
|
2011-11-02 |
2014-09-10 |
Vertex Pharmaceuticals Incorporated |
Use of (n- [2, 4 -bis (1, 1 -dimethylethyl) - 5 - hydroxyphenyl]- 1, 4 - dihydro - 4 - oxoquinoline - 3 - carboxamide) for treating cftr mediated diseases
|
|
US20140127901A1
(en)
|
2012-11-08 |
2014-05-08 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Low-k damage free integration scheme for copper interconnects
|
|
IN2014KN00885A
(https=)
|
2011-11-08 |
2015-10-02 |
Vertex Pharma |
|
|
WO2013112804A1
(en)
|
2012-01-25 |
2013-08-01 |
Vertex Pharmaceuticals Incorporated |
Formulations of 3-(6-(1-(2.2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
|
EP2819670A1
(en)
|
2012-02-27 |
2015-01-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administration thereof
|
|
US8674108B2
(en)
|
2012-04-20 |
2014-03-18 |
Vertex Pharmaceuticals Incorporated |
Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
JP2013253790A
(ja)
*
|
2012-06-05 |
2013-12-19 |
Chube Univ |
ニバレノールの分析法
|
|
AU2013270681A1
(en)
|
2012-06-08 |
2014-12-18 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for the treatment of CFTR -mediated disorders
|
|
WO2014014841A1
(en)
|
2012-07-16 |
2014-01-23 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions of (r)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
|
|
CN102788834B
(zh)
*
|
2012-08-29 |
2015-06-03 |
浙江农林大学 |
水果可溶性糖快速测定方法
|
|
KR101455694B1
(ko)
*
|
2012-09-18 |
2014-11-03 |
학교법인 선목학원 |
에틸아세테이트 및 아세토니트릴의 유기용매 혼합액을 이용한 액체-액체 추출법을 포함하는 약물 검출법
|
|
US20140092376A1
(en)
|
2012-10-01 |
2014-04-03 |
Momentive Performance Materials, Inc. |
Container and method for in-line analysis of protein compositions
|
|
LT3470063T
(lt)
|
2012-11-02 |
2025-02-10 |
Vertex Pharmaceuticals Incorporated |
Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui
|
|
US9636301B2
(en)
*
|
2012-12-04 |
2017-05-02 |
Arbutus Biopharma Corporation |
In vitro release assay for liposome encapsulated vincristine
|
|
US20140221424A1
(en)
|
2013-01-30 |
2014-08-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for use in the treatment of cystic fibrosis
|
|
CN103264029B
(zh)
*
|
2013-05-06 |
2015-03-25 |
深圳市华星光电技术有限公司 |
一种色谱分析样品瓶清洗装置及清洗方法
|
|
CN103743826B
(zh)
*
|
2013-08-28 |
2015-12-02 |
合肥久诺医药科技有限公司 |
一种阿齐沙坦的高效液相色谱分析方法
|
|
CN103822976B
(zh)
*
|
2013-10-15 |
2015-05-27 |
辽宁省食品药品检验所 |
一种测定化妆品中4-甲氧基水杨酸钾的方法
|
|
ES2885181T3
(es)
|
2014-04-15 |
2021-12-13 |
Vertex Pharma |
Composiciones farmacéuticas para el tratamiento de enfermedades mediadas por el regulador de la conductancia transmembrana de fibrosis quística
|
|
CN104090038B
(zh)
*
|
2014-07-07 |
2015-09-30 |
黄宏南 |
一种直接测定冬虫夏草产品中冬虫夏草多糖肽含量的方法
|
|
CN104122345B
(zh)
*
|
2014-07-31 |
2015-08-12 |
国家烟草质量监督检验中心 |
烟用纸中1,1,1-三羟甲基丙烷的测定方法
|
|
CN104122346B
(zh)
*
|
2014-07-31 |
2016-03-16 |
国家烟草质量监督检验中心 |
一种水基胶中尿素含量的测定方法
|
|
TWI735416B
(zh)
|
2014-10-06 |
2021-08-11 |
美商維泰克斯製藥公司 |
囊腫纖維化症跨膜傳導調節蛋白之調節劑
|
|
KR20170063954A
(ko)
|
2014-10-07 |
2017-06-08 |
버텍스 파마슈티칼스 인코포레이티드 |
낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정
|
|
WO2016086136A1
(en)
|
2014-11-26 |
2016-06-02 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid cysteamine conjugates of cftr modulators and their use in treating medical disorders
|
|
MA41031A
(fr)
|
2014-11-26 |
2017-10-03 |
Catabasis Pharmaceuticals Inc |
Conjugués cystéamine-acide gras et leur utilisation comme activateurs de l'autophagie
|
|
US10414768B2
(en)
|
2014-12-05 |
2019-09-17 |
Centre National De La Recherche Scientifique (Cnrs) |
Compounds for treating cystic fibrosis
|
|
JP6662885B2
(ja)
|
2015-01-26 |
2020-03-11 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
カルボン酸生物学的等価体としてのテトラゾロン
|
|
TWI730959B
(zh)
|
2015-05-19 |
2021-06-21 |
英商葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之雜環醯胺
|
|
CN105890945A
(zh)
*
|
2016-04-01 |
2016-08-24 |
中国热带农业科学院分析测试中心 |
超声离心渗液进样快速测定土壤中速效钾的方法
|